The 2021 Expanded Access Summit ® is on hold and will not be held on its originally scheduled dates (Sept 27-30).
Join our free membership list for alerts.
The Expanded Access Summit® is the world’s largest annual conference on pre-market access to medicines. The Summit focuses on the core feasibility factors and the innovations that enable greater use of Expanded Access and other "treatment-use" trials. Join us at EA4-Virtual as we again set new best practices for integrating research into modern healthcare for everyone.
Janet Woodcock, MD; FDA
Expanded Access 3.0, January 28, 2020
Hilary Marston, MD, MPH; NIAID, NIH
Expanded Access 3.0, January 28, 2020
Michael Kurilla, MD, PhD; NCATS, NIH
Expanded Access 3.0, January 28, 2020
The Expanded Access Summit® was launched in 2017 to provide a best-practices forum for thought leaders from the highest level of leadership in industry, clinical care, patient advocacy, and government. It has since become the world’s largest and most influential annual conference on pre-market access to medicines.
Each year the Summit examines the four major feasibility factors of pre-market access:
Operational efficiency
Learning outcomes and research value
Financial collaboration, cost recovery, and reimbursement from payers
Alignment with healthcare delivery organizations
Expanded Access 4.0 Program
Join us each day for professionally mastered livestreams of panelists, slides, and Q&A sessions.
CE / CME accreditation is available.
Day 1
Theme: “Hardcore History”, An Innovators Toolkit for EA
Sept 27, 11:00am – 3:00pm EST
Theme: “Hardcore History”, An Innovators Toolkit for EA
Session 1
“The Truth Behind the Headlines”: Expanded Access over 30 years
Networking Intermission
Session 2
Global regulatory landscapes, expectations, and business doctrine
Day 2
Theme: The Research Value of Modern Early-Access Programs
Sept 28, 11:00am – 3:00pm EST
Theme: The Research Value of Modern Early-Access Programs
Session 1
New tech for including more patients in clinical development
Networking Intermission
Session 2
Learning more and (more-efficiently) from treatment programs
Day 3
Theme: The Healthcare Value of Modern Early-Access Programs
Sept 29, 11:00am – 3:00pm EST
Theme: The Healthcare Value of Modern Early-Access Programs
Session 1
The value prospect for HCPs, hospitals, and health systems
Networking Intermission
Session 2
The value prospect for government and private health plans
Day 4
Theme: X-Factors of Radical Change in Healthcare Product Access
Sept 30, 11:00am – 3:00pm EST
Theme: X-Factors of Radical Change in Healthcare Product Access
Session 1
Speed round and interactive challenge
Special program with audience participation / breakout & report
Session 2
Partnering event, wrap-up, and prizes
Previous Speakers Include:
Janet WoodCock, MD
Toni Fauci, MD
Chris Austin, MD
Robert Walker, MD
Marjorie Speers, PhD
MICHAEL KURILLA, MD, PHD
MARC BOUTIN, JD
SUANNA BRUINOOGE, MPH
Register Now
Expanded Access 4.0 (virtual conference)
2021
The 4th Annual Expanded Access Summit®
The Leading Global Forum on Pre-Market Access to Medicines
| Type |
Early-Bird Pricing Through July 15, 2021 |
Standard Pricing |
|---|---|---|
| Corporate | $750 | $1100 |
| Health System / Government / Non-Profit | $200 | $250 |
|
Member of the Public / Guest Pass (No partnering meetings, no affiliation displayed) |
$50 | $60 |
| Entrepreneur | Contact Us | Contact Us |
- Four hours of live programming each day
- Access to “on-demand” premium content (explainers, case interviews, etc.)
- Separate “Innovator Showcase” presentations at the end of each live broadcast
- Interactive exhibits
- Breakout chat and discussion groups
- One-on-One Partnering event
Sponsors and Partners
